Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Pharmacokinetics, Clinical Efficacy and Safety of C1 Inhibitor Concentrate (C1-Esteraseremmer-N) for the Treatment of Hereditary (and Acquired) Angioedema

NCT00119431 is registered in ClinicalTrials.gov with Prothya Biosolutions as lead sponsor.

NCT NCT00119431
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00119431 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Pharmacokinetics, Clinical Efficacy and Safety of C1 Inhibitor Concentrate (C1-Esteraseremmer-N) for the Treatment of Hereditary (and Acquired) Angioedema
Lead sponsor
Prothya Biosolutions
Phase
Phase 2
Overall status
Completed
Start date
September 30, 2005
Completion date
March 31, 2006
Enrollment
12 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

angioneurotic edema, hereditary angioedema type i